InvestorsHub Logo

2business

09/02/23 2:10 PM

#185469 RE: Timing101 #185467

Tim1..If 000,-00..buyers..posted./.Re:Our..GOV'..OKing..otc.stink/aa.."Let.Them.EAT.Cake.=more..honest opinions
Then there would be more discussed if .. we don't know how many emailed against
FNRA Approval and not all are

Noted some hoping large holdings keeps them safe
Some are not delighted .. to see and
Some are not with enough understanding in a general sense on most

falon

09/04/23 9:31 AM

#185515 RE: Timing101 #185467

This closes the gap a bit.

There is still a 7 or 8 year gap:

Barry Kostiner became our Chief Financial Officer in October 2018. Prior to joining Ameri, Mr. Kostiner served as an advisor on capital markets
and business development to LinKay Technologies, Inc. a company specializing in artificial intelligence technologies, which Mr. Kostiner joined in April
2017. From November 2017 to October 2018, Mr. Kostiner also served as a consultant on data analytics and mergers and acquisition strategy to Cypress
Skilled Nursing, a skilled nursing services company. From January 2011 to October 2018, Mr. Kostiner served as a principal at Three Pillars Energy, a
consulting company.
From June 2013 to March 2015, he was a portfolio manager with Platinum Management, a multi-strategy hedge fund. Mr. Kostiner
holds a bachelor of science degree in electrical engineering and a master of science degree in operations research from the Massachusetts Institute of
Technology.

https://stocklight.com/stocks/us/manufacturing/nasdaq-envb/enveric-biosciences/annual-reports/nasdaq-envb-2019-10K-19781535.pdf


Nope only a few years left:

Mr. Kostiner was the CFO of Ameri Holdings Inc. (Nasdaq: AMRH) from October 2018 through December 2020. The operations of AMRH, including its global IT services business focused on SAP with operations in both the US and India, was acquired by management, with the residual Nasdaq vehicle acquired by Enveric Biosciences (Nasdaq: ENVB), an evidence-based cannabinoid pharma company focused on palliative therapies for cancer patients. Mr. Kostiner has been a consultant to ENVB since January 2021. From May 2016 through October 2018, Mr. Kostiner was a consultant to Cypress Skilled Nursing, a healthcare facility operator and from May 2017 through October 2018 he was a consultant to LinKay Technologies Inc., an artificial intelligence incubator with a portfolio of intellectual property focused on AI and LiDAR / geospatial technology, with research staff in India and New York. Mr. Kostiner’s 20-year career in energy includes eight years at Goldman Sachs and Merrill Lynch and their affiliates, with a focus on energy trading and portfolio management, as well as serving as the CEO of an oil & gas SPAC (Nasdaq: PGRI) from 2005 through 2009. Mr. Kostiner earned a Bachelor’s of Science degree in Electrical Engineering and a Master’s of Science in Operations Research from MIT. His thesis on the mathematics of electric industry deregulation was sponsored by Harvard’s Kennedy School of Government.

https://www.sec.gov/Archives/edgar/data/1855351/000149315221012899/forms-1.htm
Bullish
Bullish